Hudplejeklinikken B-Unique ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 22.7% 29.4% 20.9%  
Credit score (0-100)  0 0 3 1 5  
Credit rating  N/A N/A B C B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 580 805 1,028  
EBITDA  0.0 0.0 -39.8 -88.0 201  
EBIT  0.0 0.0 -91.1 -150 139  
Pre-tax profit (PTP)  0.0 0.0 -121.5 -183.0 103.6  
Net earnings  0.0 0.0 -96.1 -143.4 80.7  
Pre-tax profit without non-rec. items  0.0 0.0 -122 -183 104  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  0.0 0.0 36.1 19.4 2.8  
Shareholders equity total  0.0 0.0 -56.1 -199 -119  
Interest-bearing liabilities  0.0 0.0 8.3 16.2 17.0  
Balance sheet total (assets)  0.0 0.0 896 1,016 984  

Net Debt  0.0 0.0 -160 -249 -341  
 
See the entire balance sheet

Volume 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 580 805 1,028  
Gross profit growth  0.0% 0.0% 0.0% 38.8% 27.7%  
Employees  0 0 3 3 3  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 896 1,016 984  
Balance sheet change%  0.0% 0.0% 0.0% 13.3% -3.1%  
Added value  0.0 0.0 -39.8 -98.3 200.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 397 -123 -123  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 1.0  

Profitability 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% -15.7% -18.6% 13.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -9.6% -13.8% 12.1%  
ROI %  0.0% 0.0% -1,096.2% -1,222.0% 846.2%  
ROE %  0.0% 0.0% -10.7% -15.0% 8.1%  

Solidity 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  0.0% 0.0% -5.9% -16.4% -10.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 401.5% 283.4% -169.7%  
Gearing %  0.0% 0.0% -14.8% -8.1% -14.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 730.9% 271.8% 222.4%  

Liquidity 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  0.0 0.0 1.6 1.7 2.8  
Current Ratio  0.0 0.0 2.1 2.2 3.3  
Cash and cash equivalent  0.0 0.0 167.9 265.6 358.0  

Capital use efficiency 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 238.2 339.2 459.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
N/A
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -13 -33 67  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -13 -29 67  
EBIT / employee  0 0 -30 -50 46  
Net earnings / employee  0 0 -32 -48 27